GO:0005745 m-AAA complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005745 (m-AAA complex) is a mitochondrial inner membrane protease complex that handles protein turnover and processing of imported proteins.
• The complex is built from AAA+ ATPase subunits such as AFG3L2 and SPG7, which form hexameric assemblies in the inner membrane.
• m-AAA activity controls key mitochondrial calcium machinery, including processing of MCU for uniporter assembly and regulation of the permeability transition pore.
• Loss of m-AAA function is linked to neurodegeneration, including hereditary spastic paraplegia and AFG3L2-related neurologic disorders.
• The m-AAA complex also regulates the mitochondrial magnesium channel and is sensitive to the proton gradient.
• CRISPR knockout, point-mutation, knock-in and overexpression models are central tools for dissecting m-AAA subunit function in mitochondria.
Description
The m-AAA complex (GO:0005745) is a protease complex of the mitochondrial inner membrane that is involved in mitochondrial protein turnover and in processing of proteins imported into mitochondria. It belongs to the AAA+ family of ATP-dependent proteases and is a central node in mitochondrial proteostasis, the network that maintains a functional mitochondrial proteome. Because mitochondria cannot rely on the cytosolic degradation machinery for inner-membrane proteins, the m-AAA complex provides a dedicated quality-control and processing activity at the inner membrane. Researchers study GO:0005745 because its substrates include calcium and magnesium transport components, and because its dysfunction is directly connected to human neurologic disease. The complex is best known through its AAA+ ATPase subunits AFG3L2 and SPG7, which assemble into hexameric rings and use ATP hydrolysis to unfold and process or degrade substrate proteins. In recent years, work has shown that m-AAA activity is not static: it responds to the mitochondrial proton gradient and participates in adaptation to elevated mitochondrial calcium. This makes GO:0005745 a convergence point for mitochondrial biology, calcium signaling, neurodegeneration and organelle quality control.
m-AAA complex At A Glance
| GO ID | GO:0005745 |
|---|---|
| GO term | m-AAA complex |
| Ontology | cellular_component |
| Synonym | none listed in QuickGO |
| Major function | ATP-dependent protease complex of the mitochondrial inner membrane that performs mitochondrial protein turnover and processing of imported proteins |
| Subunit class | AAA+ ATPase subunits, including AFG3L2 and SPG7 |
| Subcellular location | Mitochondrial inner membrane |
| Key substrates/processes | MCU processing for uniporter assembly, mitochondrial magnesium channel regulation, permeability transition pore regulation |
| Disease relevance | Hereditary spastic paraplegia and AFG3L2-related neurologic disorders |
What Is GO:0005745?
In plain terms, GO:0005745 describes a protein-cutting machine anchored in the mitochondrial inner membrane. The QuickGO definition states that it is a protease complex of the mitochondrial inner membrane involved in mitochondrial protein turnover and in processing of proteins imported into mitochondria. Functionally, this means the m-AAA complex both removes damaged or excess inner-membrane proteins and trims newly imported proteins to their mature forms. It is an ATP-dependent AAA+ protease, so its proteolytic and processing activities are powered by ATP hydrolysis. The complex is therefore a component of the mitochondrial proteostasis system rather than a generic cytosolic protease.
Why Is m-AAA complex Important in Cell Biology?
GO:0005745 matters because the m-AAA complex sits at the interface of mitochondrial protein quality control and mitochondrial signaling. It processes imported proteins and turns over inner-membrane proteins, so its activity shapes the composition and function of the mitochondrial inner membrane. It also directly regulates calcium and magnesium transport components, including MCU processing for uniporter assembly and the mitochondrial magnesium channel. Because mitochondrial calcium overload and permeability transition are central to cell death and neurodegeneration, m-AAA dysfunction has direct pathophysiological consequences. Mutations in m-AAA subunits are associated with hereditary spastic paraplegia and AFG3L2-related neurologic disorders, making the complex a clinically relevant research target. Finally, m-AAA activity is modulated by the proton gradient, linking mitochondrial energetics to proteostasis.
• Maintains mitochondrial proteostasis by degrading and processing inner-membrane proteins.
• Processes MCU to support uniporter assembly and mitochondrial calcium influx.
• Regulates opening of the mitochondrial permeability transition pore.
• Controls the mitochondrial magnesium channel together with the prohibitin complex.
• Responds to the mitochondrial proton gradient, coupling energetics to proteolysis.
• Is required for normal adaptation to elevated mitochondrial calcium in cardiac tissue.
• Its dysfunction causes or contributes to hereditary spastic paraplegia.
• Mutations in AFG3L2 are linked to AFG3L2-related neurologic disorders.
• Provides a model system for studying AAA+ protease mechanism and substrate recognition.
• Is a candidate target for experimental modulation of mitochondrial calcium handling.
m-AAA complex: Biological Process, Cellular Component and Molecular Function
Protein turnover at the inner membrane
In simple terms: The m-AAA complex acts like a recycling and trimming machine for proteins in the mitochondrial inner membrane.
The m-AAA complex is involved in mitochondrial protein turnover, meaning it removes proteins that are damaged, misfolded or no longer needed. This turnover is part of mitochondrial proteostasis and helps preserve inner-membrane function under stress. Because the complex is ATP-dependent, substrate unfolding and proteolysis are coupled to ATP hydrolysis by its AAA+ domains. Loss of this turnover activity can allow abnormal proteins to accumulate and impair mitochondrial function.
Processing of imported proteins
In simple terms: Many proteins are imported into mitochondria as longer precursors, and the m-AAA complex helps cut them to their working size.
The QuickGO definition explicitly includes processing of proteins imported into mitochondria. This processing step converts precursor or intermediate forms into mature proteins, which is essential for assembly of inner-membrane complexes. A well-studied example is the processing of MCU, which is required for uniporter assembly and subsequent calcium influx. Thus, the m-AAA complex functions not only as a degradation machine but also as a maturation factor for imported mitochondrial proteins.
Regulation of mitochondrial calcium and the permeability transition pore
In simple terms: By cutting MCU, the m-AAA complex controls how much calcium enters mitochondria and when the permeability transition pore opens.
SPG7 targets the m-AAA protease complex to process MCU, which is required for uniporter assembly, calcium influx and regulation of mitochondrial permeability transition pore opening. This places the m-AAA complex upstream of mitochondrial calcium overload, a key trigger of cell death. m-AAA proteases are therefore central to mitochondrial calcium homeostasis and neurodegeneration. In cardiac tissue, adaptation to elevated mitochondrial calcium is distinct in the left and right ventricles, indicating context-dependent regulation of these pathways.
Regulation of the mitochondrial magnesium channel
In simple terms: The m-AAA complex also helps control magnesium entry into mitochondria by working with the prohibitin complex.
Proteolytic regulation of the mitochondrial magnesium channel by the m-AAA protease and prohibitin complex has been demonstrated. This links GO:0005745 to mitochondrial metal homeostasis beyond calcium. Because magnesium is required for many mitochondrial enzymes and for ATP handling, this regulation has broad metabolic implications. The coordination between m-AAA and prohibitin highlights that the complex operates within a larger inner-membrane protein network.
Coupling to the proton gradient
In simple terms: The m-AAA complex does not work in isolation; its activity is influenced by the energy state of the mitochondrion.
Regulation of mitochondrial proteostasis by the proton gradient has been reported, showing that m-AAA-dependent processes are sensitive to the inner-membrane proton motive force. This means that changes in mitochondrial respiration or membrane potential can alter how effectively the complex carries out turnover and processing. Such coupling allows the mitochondrion to adjust proteostasis according to its energetic status. It also provides an experimental handle: manipulating the proton gradient can reveal m-AAA-dependent phenotypes.
AAA+ mechanism and substrate handling
In simple terms: The m-AAA complex uses ATP-powered ring-shaped motors to pull proteins into a chamber where they are cut.
Molecular mechanisms of mitochondrial AAA+ proteases have been reviewed, describing how AAA+ domains unfold substrates and translocate them to proteolytic sites. The m-AAA complex is built from AAA+ ATPase subunits such as AFG3L2 and SPG7, which assemble into hexameric rings in the inner membrane. Substrate recognition and processing specificity determine which imported proteins are matured and which are degraded. This mechanism explains why mutations in AAA+ domains can selectively impair calcium handling and neuronal survival.
Key Genes Involved in GO:0005745 m-AAA complex
The following genes and proteins are the principal components, regulators and substrates associated with the m-AAA complex (GO:0005745) in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AFG3L2 | AAA+ ATPase subunit of the m-AAA complex; core catalytic and structural component | Mutations cause AFG3L2-related neurologic disorders; key target for neurodegeneration studies |
| SPG7 | AAA+ ATPase subunit that targets the m-AAA complex to process MCU | Mutations linked to hereditary spastic paraplegia; central to calcium and permeability transition research |
| MCU | Mitochondrial calcium uniporter; processed by m-AAA to support uniporter assembly | Readout for m-AAA-dependent calcium influx and permeability transition pore regulation |
| PHB | Prohibitin complex component cooperating with m-AAA in magnesium channel regulation | Used to study inner-membrane proteostasis networks |
| PHB2 | Prohibitin complex component implicated with m-AAA in mitochondrial regulation | Candidate modifier in m-AAA-related mitochondrial phenotypes |
| MICU1 | Mitochondrial calcium uptake regulator functionally downstream of MCU processing | Used to interpret m-AAA effects on calcium homeostasis |
| MICU2 | Mitochondrial calcium uptake regulator functionally downstream of MCU processing | Context for m-AAA-dependent calcium phenotypes |
| VDAC1 | Outer membrane channel influencing mitochondrial calcium and energetics | Background gene for calcium and permeability transition studies |
| PPIF | Cyclophilin D, a regulator of the permeability transition pore | Readout for m-AAA-dependent permeability transition pore opening |
| OPA1 | Inner-membrane dynamin-like GTPase in mitochondrial dynamics | Comparative inner-membrane proteostasis and dynamics studies |
| YME1L | Mitochondrial i-AAA protease with complementary inner-membrane quality control roles | Comparative AAA+ protease studies |
| CLPP | Mitochondrial matrix AAA+ protease | Comparative mitochondrial proteostasis studies |
| LONP1 | Mitochondrial matrix AAA+ protease | Comparative mitochondrial proteostasis studies |
| ATAD3A | Inner-membrane AAA+ ATPase involved in mitochondrial organization | Context for inner-membrane AAA+ protein networks |
| SLC25A family | Mitochondrial carrier proteins that depend on inner-membrane proteostasis | Substrate context for m-AAA-dependent turnover |
| MT-ATP6 | Mitochondrial ATP synthase subunit reflecting inner-membrane integrity | Readout for proton-gradient-dependent proteostasis |
| MT-CO1 | Mitochondrial cytochrome c oxidase subunit reflecting inner-membrane function | Readout for mitochondrial proteostasis and respiration |
| TFAM | Mitochondrial transcription factor influencing mitochondrial gene expression | Context for mitochondrial proteostasis and biogenesis |
How Is m-AAA complex Regulated?
The m-AAA complex is regulated at multiple levels. Its activity is influenced by the mitochondrial proton gradient, linking proteostasis to the energetic state of the organelle. Substrate availability, including imported proteins such as MCU, determines when processing occurs and thus controls uniporter assembly and calcium influx. The complex also cooperates with the prohibitin complex in regulating the mitochondrial magnesium channel, indicating that inner-membrane protein complexes modulate its functions. In cardiac tissue, adaptation to elevated mitochondrial calcium differs between the left and right ventricles, suggesting that m-AAA-dependent pathways are tuned in a tissue- and context-specific manner. Finally, the AAA+ mechanism itself imposes regulation through ATP binding and hydrolysis, which governs substrate unfolding and translocation.
m-AAA complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SPG7 | Hereditary spastic paraplegia; MCU processing and permeability transition pore regulation | SPG7 knockout or point-mutation cell models with MCU processing readouts |
| AFG3L2 | AFG3L2-related neurologic disorders; mitochondrial proteostasis and calcium handling | AFG3L2 knock-in of patient mutations in neuronal cell lines |
| MCU | Mitochondrial calcium overload and cell death | MCU processing reporter and calcium imaging in m-AAA mutant cells |
| PHB/PHB2 | Mitochondrial magnesium channel regulation with m-AAA | Prohibitin knockout models combined with m-AAA perturbation |
| PPIF | Permeability transition pore opening downstream of m-AAA-dependent calcium regulation | PPIF knockout or tagged knock-in with permeability transition assays |
Hereditary spastic paraplegia
SPG7 targets the m-AAA protease complex to process MCU for uniporter assembly, calcium influx and regulation of mitochondrial permeability transition pore opening. Mutations affecting this pathway are linked to hereditary spastic paraplegia, a neurodegenerative disorder characterized by progressive spasticity. The m-AAA complex is therefore a direct molecular entry point into the disease mechanism. Experimental work on SPG7 and m-AAA subunits helps explain why impaired mitochondrial calcium handling damages long motor axons.
AFG3L2-related neurologic disorders
AFG3L2 is a core AAA+ ATPase subunit of the m-AAA complex, and mutations in AFG3L2 cause AFG3L2-related neurologic disorders. These conditions illustrate how disruption of mitochondrial proteostasis and calcium regulation can produce neurodegeneration. Because AFG3L2 is required for m-AAA complex function, disease mutations provide natural experiments linking GO:0005745 to neuronal survival. Research models carrying AFG3L2 mutations are used to dissect the downstream consequences for mitochondrial calcium and permeability transition.
Mitochondrial calcium overload and cell death
The m-AAA complex regulates MCU processing and permeability transition pore opening, which are central to mitochondrial calcium overload and cell death. m-AAA proteases, mitochondrial calcium homeostasis and neurodegeneration are mechanistically connected. When m-AAA function is compromised, uniporter assembly and calcium influx can become dysregulated, sensitizing cells to stress. This pathway is relevant not only to neurodegeneration but also to cardiac adaptation to elevated mitochondrial calcium.
Mitochondrial proteostasis and metal homeostasis
Beyond calcium, the m-AAA complex regulates the mitochondrial magnesium channel together with the prohibitin complex. This places GO:0005745 in the broader context of mitochondrial metal homeostasis and inner-membrane quality control. Defects in mitochondrial proteostasis can impair respiratory chain function and organelle integrity. Studying m-AAA substrates therefore provides insight into how mitochondrial dysfunction contributes to disease.
From m-AAA complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What happens when m-AAA catalytic activity is lost? | AFG3L2 or SPG7 knockout cell lines |
| How does a patient mutation alter substrate processing? | Point-mutation knock-in of AFG3L2 or SPG7 variants |
| Where and when does the complex act on substrates? | Tagged knock-in of m-AAA subunits for imaging and proteomics |
| Does excess m-AAA activity change calcium handling? | Overexpression of AFG3L2 or SPG7 in mitochondrial reporter cells |
| How does the proton gradient control m-AAA-dependent proteostasis? | Cells with controlled mitochondrial uncoupling or respiration mutants |
| Which substrates depend on m-AAA for maturation? | Knockout plus proteomics and MCU processing assays |
How to Study the m-AAA complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry proteomics | Protein abundance and processing states | Identify m-AAA substrates and turnover targets |
| Immunoblotting | Processing of specific substrates such as MCU | Assess uniporter assembly and maturation |
| Mitochondrial calcium imaging | Calcium influx and retention | Link m-AAA function to calcium homeostasis |
| Permeability transition pore assays | Pore opening sensitivity | Test downstream consequences of m-AAA activity |
| Respirometry | Mitochondrial respiration and proton gradient | Determine energetic regulation of proteostasis |
| Fluorescence microscopy | Localization and assembly of tagged subunits | Study inner-membrane complex dynamics |
| CRISPR knockout screening | Gene requirements for m-AAA-dependent phenotypes | Discover modifiers of mitochondrial calcium and proteostasis |
| Transcriptomics | Gene expression changes after m-AAA perturbation | Identify stress and adaptation pathways |
Proteomics and substrate identification
Mass spectrometry-based proteomics is used to identify proteins whose abundance or processing state changes when m-AAA subunits are lost or mutated. Because the complex handles both turnover and processing, proteomics can distinguish degradation substrates from maturation substrates. Comparative proteomics between wild-type and AFG3L2 or SPG7 knockout cells reveals candidate substrates and pathways. This approach is often combined with subcellular fractionation to enrich mitochondrial inner-membrane proteins.
Calcium and mitochondrial function assays
Mitochondrial calcium imaging and permeability transition pore assays are used to measure the functional consequences of m-AAA activity. MCU processing can be monitored by immunoblotting to assess uniporter assembly and calcium influx capacity. These assays connect molecular changes in GO:0005745 to organelle physiology and cell death. In cardiac studies, similar approaches reveal ventricle-specific adaptation to elevated mitochondrial calcium.
Respiration and proton-gradient measurements
Respirometry and membrane potential measurements assess the proton gradient that regulates m-AAA-dependent proteostasis. These methods test whether changes in mitochondrial energetics alter substrate processing or turnover. Combining respiration data with proteomics helps determine whether phenotypes are driven by proteostasis or by bioenergetic failure. Such experiments are essential for interpreting m-AAA function in disease models.
Imaging and tagged subunit localization
Fluorescence imaging of tagged m-AAA subunits reveals their localization and assembly in the mitochondrial inner membrane. Tagged knock-in models allow dynamic tracking of complex behavior under stress. Co-localization with inner-membrane markers and calcium sensors links complex position to function. These imaging approaches complement biochemical assays of protease activity.
How CRISPR Can Be Used to Study GO:0005745 m-AAA complex
Knockout
CRISPR knockout of AFG3L2 or SPG7 is used to eliminate m-AAA complex activity and reveal its substrates and phenotypes. Knockout cells show altered MCU processing, calcium handling and permeability transition pore regulation. These models are foundational for assigning function to GO:0005745 in a clean genetic background. They can be combined with proteomics to identify turnover and processing targets.
Point Mutation
Point-mutation knock-in models introduce disease-associated variants into AFG3L2 or SPG7 to test selective loss of function. Such models distinguish catalytic defects from structural or assembly defects. They are particularly useful for AFG3L2-related neurologic disorders, where patient mutations may impair specific substrate interactions. Point mutants can be compared with knockouts to separate complete loss from partial dysfunction.
Knock-in
Tagged knock-in of m-AAA subunits enables visualization, immunoprecipitation and interaction studies in a native context. Knock-in reporters can also be used to monitor substrate processing in live cells. These models preserve endogenous regulation, which is important because m-AAA activity is sensitive to the proton gradient. They support detailed mechanistic studies of complex assembly and substrate handling.
Overexpression
Overexpression of AFG3L2 or SPG7 is used to test whether increased m-AAA activity alters mitochondrial calcium handling or proteostasis. Gain-of-function experiments can reveal rate-limiting steps in substrate processing. Overexpression models are also useful for biochemical purification of the complex for structural and enzymatic studies. They complement loss-of-function approaches to build a complete picture of GO:0005745 function.
How EDITGENE Supports m-AAA complex Research
Researchers studying m-AAA complex-related genes often need to determine whether a candidate gene is causally involved in mitochondrial proteostasis, calcium handling or neurodegeneration. EDITGENE provides the CRISPR cell models and screening services needed to move from correlation to mechanism.
Contact EDITGENE today to design your custom CRISPR model for m-AAA complex research.
Frequently Asked Questions About m-AAA complex
What is the m-AAA complex (GO:0005745)?
The m-AAA complex is a protease complex of the mitochondrial inner membrane involved in mitochondrial protein turnover and in processing of proteins imported into mitochondria.
What genes are involved in the m-AAA complex?
Core genes include AFG3L2 and SPG7, which encode AAA+ ATPase subunits of the complex.
Where is the m-AAA complex located?
It is located in the mitochondrial inner membrane.
What does the m-AAA complex do?
It degrades and processes inner-membrane proteins, including processing of MCU for uniporter assembly and regulation of the permeability transition pore.
How is the m-AAA complex regulated?
Its activity is influenced by the mitochondrial proton gradient and by cooperation with the prohibitin complex in magnesium channel regulation.
What diseases are linked to m-AAA complex dysfunction?
Dysfunction is linked to hereditary spastic paraplegia and AFG3L2-related neurologic disorders.
How does the m-AAA complex affect mitochondrial calcium?
It processes MCU to support uniporter assembly, calcium influx and permeability transition pore regulation.
What experimental models are used to study the m-AAA complex?
CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression cell models are widely used.
Which methods identify m-AAA substrates?
Proteomics, immunoblotting and mitochondrial functional assays are commonly used to identify and validate substrates.
Why is the m-AAA complex important for neurodegeneration research?
Because it controls mitochondrial calcium and proteostasis, and its subunits are mutated in neurodegenerative disorders.
Conclusion
GO:0005745 describes the m-AAA complex, an ATP-dependent protease complex of the mitochondrial inner membrane that performs protein turnover and processing of imported proteins. Its subunits, including AFG3L2 and SPG7, connect mitochondrial proteostasis to calcium and magnesium handling, permeability transition pore regulation and neuronal survival. Because mutations in these subunits cause hereditary spastic paraplegia and AFG3L2-related neurologic disorders, the complex is a high-value target for mechanistic and translational research. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with proteomics and functional assays, provide the experimental framework needed to dissect m-AAA biology.
References
- 1. Joshi A et al.. 2025. Proteolytic regulation of mitochondrial magnesium channel by m-AAA protease and prohibitin complex.. Genetics 229(2) PMID: 39657011
- 2. Patron M et al.. 2018. m-AAA proteases, mitochondrial calcium homeostasis and neurodegeneration.. Cell Res 28(3):296-306 PMID: 29451229
- 3. Patron M et al.. 2022. Regulation of mitochondrial proteostasis by the proton gradient.. EMBO J 41(16):e110476 PMID: 35912435
- 4. Adam MP et al.. 1993. AFG3L2-Related Neurologic Disorders.. PMID: 21595125
- 5. Hurst S et al.. 2019. SPG7 targets the m-AAA protease complex to process MCU for uniporter assembly, Ca(2+) influx, and regulation of mitochondrial permeability transition pore opening.. J Biol Chem 294(28):10807-10818 PMID: 31097542
- 6. Pakkiriswami S et al.. 2025. Adaptation to Elevated Mitochondrial Calcium Is Distinct in the Left and Right Ventricles.. Circ Res 137(10):e197-e217 PMID: 41054844
- 7. Adam MP et al.. 1993. Uncomplicated (Pure) Hereditary Spastic Paraplegia Overview.. PMID: 20301682
- 8. Currie SQW et al.. 2026. Molecular mechanisms of mitochondrial AAA+ proteases.. J Biol Chem 302(3):111264 PMID: 41655698
